Predictive factors and pharmacological preventive interventions for atrial fibrillation after aortic valve replacement
- PMID: 40783759
- PMCID: PMC12335050
- DOI: 10.1186/s13019-025-03577-6
Predictive factors and pharmacological preventive interventions for atrial fibrillation after aortic valve replacement
Abstract
Objective: This study aims to investigate the predictive factors for postoperative atrial fibrillation (POAF) following aortic valve replacement (AVR) and evaluate the preventive effect of combined atorvastatin and metoprolol therapy on POAF.
Methods: This study employed a mixed design of retrospective cohort analysis and prospective randomized controlled trial, including 268 patients who underwent isolated AVR from January 1, 2022, to March 31, 2024. The 168 patients from January 1, 2022, to May 31, 2023, were analyzed for POAF predictive factors, while 100 patients from June 1, 2023, were included in the prospective trial. The intervention group (n = 50) received combined atorvastatin and metoprolol treatment starting 7 days before surgery.
Results: Multivariate logistic regression analysis identified age (OR = 1.12, 95% CI: 1.04–1.20, p = 0.003), history of stroke (OR = 10.94, 95% CI: 1.32–90.66, p = 0.027), EuroSCORE II (OR = 2.90, 95% CI: 1.61–5.20, p < 0.001), NT-proBNP level (OR = 1.002, 95% CI: 1.001–1.004, p = 0.009), hs-CRP level (OR = 1.55, 95% CI: 1.16–2.07, p = 0.003), and operation time (OR = 1.02, 95% CI: 1.01–1.04, p = 0.008) as independent predictors of POAF. Pharmacological intervention significantly reduced POAF incidence (p = 0.005) and shortened hospital stay (p < 0.001), ICU stay (p = 0.002), and mechanical ventilation time (p < 0.001). The AUC of the predictive model was 0.952, with a calibrated C-statistic of 0.904. Decision curve analysis demonstrated significant clinical utility across multiple risk thresholds.
Conclusion: Age, history of stroke, EuroSCORE II, NT-proBNP and hs-CRP levels, and operation time are independent predictors of POAF. Combined preventive treatment with atorvastatin and metoprolol reduced POAF incidence and postoperative hospital stay, showing promising clinical application prospects.
Keywords: Atorvastatin; Metoprolol; Pharmacological prevention; Postoperative atrial fibrillation after aortic valve replacement; Predictive factors.
Conflict of interest statement
Declarations. Ethical statement: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Transoesophageal echocardiography for prediction of postoperative atrial fibrillation after isolated aortic valve replacement: two-dimensional speckle tracking for intraoperative assessment of left ventricular longitudinal strain.Eur J Cardiothorac Surg. 2015 May;47(5):833-9. doi: 10.1093/ejcts/ezu234. Epub 2014 Jun 11. Eur J Cardiothorac Surg. 2015. PMID: 24920107
-
Impact of Atrial Fibrillation Type on Outcomes of Transcatheter Aortic Valve Replacement for Aortic Stenosis: A Single-Center Analysis.Tex Heart Inst J. 2024 Dec 12;51(2):e248402. doi: 10.14503/THIJ-24-8402. eCollection 2024 Jul-Dec. Tex Heart Inst J. 2024. PMID: 39677398 Free PMC article.
-
Comparison of efficacy and safety between VKAs and DOACs in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis.Clin Cardiol. 2022 Oct;45(10):1002-1010. doi: 10.1002/clc.23909. Epub 2022 Aug 28. Clin Cardiol. 2022. PMID: 36030549 Free PMC article.
-
Multicenter Study of Surgical Ablation for Atrial Fibrillation in Aortic Valve Replacement.ASAIO J. 2023 May 1;69(5):483-489. doi: 10.1097/MAT.0000000000001882. Epub 2023 Apr 27. ASAIO J. 2023. PMID: 37126228
-
Limited versus full sternotomy for aortic valve replacement.Cochrane Database Syst Rev. 2017 Apr 10;4(4):CD011793. doi: 10.1002/14651858.CD011793.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2023 Dec 6;12:CD011793. doi: 10.1002/14651858.CD011793.pub3. PMID: 28394022 Free PMC article. Updated.
References
-
- Siontis G, Overtchouk P, Cahill T, Modine T, Prendergast B, Praz F, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J. 2019;40(38):3143–53. 10.1093/eurheartj/ehz275 - PubMed
-
- Tummala V, Kuruvilla A, Yaligar A, Agha S, Bilfinger T, Shroyer A. Pre-operative and post-operative atrial fibrillation in patients undergoing SAVR/TAVR. Vessel Plus. 2022;6:16. 10.20517/2574-1209.2021.93
-
- Shahim B, Malaisrie S, George I, Thourani V, Biviano A, Russo M, et al. Postoperative atrial fibrillation or flutter following transcatheter or surgical aortic valve replacement: PARTNER 3 trial. JACC Cardiovasc Interv. 2021;14(14):1565–74. 10.1016/j.jcin.2021.05.017 - PubMed
-
- Lo J, Crawford J, Desmond D, Bae H, Lim J, Godefroy O, et al. Long-term cognitive decline after stroke: an individual participant data meta-analysis. Stroke. 2022;53(5):1318–27. 10.1161/STROKEAHA.121.036501 - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous